Literature DB >> 27835048

Furosemide in postpartum management of severe preeclampsia: A randomized controlled trial.

P Veena1, Lakshmideepthi Perivela1, S Soundara Raghavan1.   

Abstract

BACKGROUND: Hypertension in the postpartum period is a common phenomenon and is often a cause for concern. Following delivery, fluid that has been sequestered in the extravascular space is mobilized, producing a large auto-infusion of fluid from the extravascular to the intravascular compartment. As a result of this fluid mobilization process, there is an increase in central venous pressure and pulmonary capillary wedge pressure, which might favor the development of pulmonary edema. Thus, diuretics logically might be a better choice as antihypertensive medication in such a scenario.
METHODS: A total of 108 antenatal women diagnosed with having severe preeclampsia, with two high blood pressure recordings of ≥150/100 mm of Hg in the postpartum period within the first 24 hours of delivery, were enrolled in the study. These patients were randomly divided into two groups (Group A: furosemide 20 mg OD + nifedipine & Group B: nifedipine alone). Main outcome measures studied were reduction in systolic, diastolic, and mean arterial blood pressures, requirement of additional antihypertensive drugs to control blood pressure, duration of hospital stay, and antihypertensive requirement at discharge.
RESULTS: Both groups were comparable for distribution of age and parity and presence of imminent symptoms and eclampsia. There was no significant difference in mean systolic, diastolic, and mean arterial pressures (MAPs) between both the groups at admission. Mean gestational age at delivery was 36 weeks in both the groups. Requirement of additional antihypertensive was significantly higher in women in group B (26.0% vs. 8.0%, p = 0.017). Duration of hospital and postpartum stay and the use of antihypertensive at discharge were similar in both the groups
Conclusion: In conclusion, the use of a short course of furosemide along with nifedipine significantly reduces the need of additional antihypertensive in severe preeclamptic women with postpartum hypertension when compared to women who received nifedipine alone.

Entities:  

Keywords:  Furosemide; nifedipine; postpartum hypertension; severe preeclampsia

Mesh:

Substances:

Year:  2016        PMID: 27835048     DOI: 10.1080/10641955.2016.1239735

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  9 in total

Review 1.  Hypertensive Disorders of Pregnancy and Future Maternal Health: How Can the Evidence Guide Postpartum Management?

Authors:  Alisse Hauspurg; Malamo E Countouris; Janet M Catov
Journal:  Curr Hypertens Rep       Date:  2019-11-27       Impact factor: 5.369

2.  Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association.

Authors:  Vesna D Garovic; Ralf Dechend; Thomas Easterling; S Ananth Karumanchi; Suzanne McMurtry Baird; Laura A Magee; Sarosh Rana; Jane V Vermunt; Phyllis August
Journal:  Hypertension       Date:  2021-12-15       Impact factor: 9.897

3.  Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients with Severe Preeclampsia: A Randomized, Single-Blind, Controlled Trial.

Authors:  Gilberto Arias-Hernández; Cruz Vargas-De-León; Claudia C Calzada-Mendoza; María Esther Ocharan-Hernández
Journal:  Int J Hypertens       Date:  2020-07-23       Impact factor: 2.420

4.  Furosemide for Accelerated Recovery of Blood Pressure Postpartum in women with a hypertensive disorder of pregnancy: A Randomized Controlled Trial.

Authors:  Joana Lopes Perdigao; Jennifer Lewey; Adi Hirshberg; Nathanael Koelper; Sindhu K Srinivas; Michal A Elovitz; Lisa D Levine
Journal:  Hypertension       Date:  2021-02-08       Impact factor: 10.190

Review 5.  Postpartum management of hypertensive disorders of pregnancy: a systematic review.

Authors:  Alexandra E Cairns; Louise Pealing; James M N Duffy; Nia Roberts; Katherine L Tucker; Paul Leeson; Lucy H MacKillop; Richard J McManus
Journal:  BMJ Open       Date:  2017-11-28       Impact factor: 2.692

Review 6.  Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications.

Authors:  Wilfried Gyselaers
Journal:  J Clin Med       Date:  2019-03-11       Impact factor: 4.241

7.  Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial.

Authors:  Jahanara Ainuddin; Fariha Javed; Sarah Kazi
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

Review 8.  Cardiovascular System in Preeclampsia and Beyond.

Authors:  Basky Thilaganathan; Erkan Kalafat
Journal:  Hypertension       Date:  2019-03       Impact factor: 10.190

9.  Pre-eclampsia with severe features: management of antihypertensive therapy in the postpartum period.

Authors:  Nnabuike Chibuoke Ngene; Jagidesa Moodley
Journal:  Pan Afr Med J       Date:  2020-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.